Newronika Receives CE Mark Approval for AlphaDBS, Advancing Adaptive Deep Brain Stimulation for Parkinson's Disease

Newronika Germany Austria United Kingdom United States of America France Spain Italy New York Europe California

or follow us on LinkedIn.

Logo - https://mma.prnewswire.com/media/2612569/5150136/Newronika_Logo.jpg

Contact
Michael Fattore
CFO
[phone]
[e-mail] 

View original content:https://www.prnewswire.co.uk/news-releases/newronika-receives-ce-mark-approval-for-alphadbs-advancing-adaptive-deep-brain-stimulation-for-parkinsons-disease-302408082.html